Bone drugs for prostate cancer may result in survival benefitAugust 4, 2021Genitourinary CancerCancerOncology
Many pandemic-driven changes to cancer clinical trials should remainJuly 28, 2021COVID-19 UpdatesCancerOncologyHealth Policy
Stop using Neutrogena and Aveeno spray sunscreen, J&J warnsJuly 15, 2021Mixed TopicsMelanomaDermatologyCancerOncology
Cancer mortality continues to drop in females as breast cancer reversal loomsJuly 13, 2021Breast CancerLung CancerMelanomaWomen's HealthOncologyCancer
Racial and economic disparities persist in endometrial cancer careJune 29, 2021OncologyWomen's HealthCancer
Promising HER2+/HR– breast cancer survival with de-escalated therapyJune 15, 2021Breast CancerOncologyCancer
High Rate of Inappropriate Fecal Immunochemical Testing at a Large Veterans Affairs Health Care SystemJune 9, 2021Hospital MedicineCancerOncology
When First-Line Systemic Treatment for Hepatocellular Carcinoma Fails, What Comes Next?October 30, 2020HepatitisCancer
Implementation and Evaluation of a 90-Minute Rituximab Infusion Protocol at the Richard L. Roudebush VA Medical CenterJuly 9, 2020Hospital MedicineCancer
